Alx Oncology Holdings (ALXO) Profit After Tax (QoQ) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Alx Oncology Holdings | 189.80 Mn | 49.48 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 21.54% |
| Dec 31, 2025 | -3.18% |
| Sep 30, 2025 | 14.66% |
| Jun 30, 2025 | 15.62% |
| Mar 31, 2025 | -5.46% |
| Dec 31, 2024 | 5.03% |
| Sep 30, 2024 | 22.06% |
| Jun 30, 2024 | -10.73% |
| Mar 31, 2024 | 21.75% |
| Dec 31, 2023 | 10.82% |
| Sep 30, 2023 | -49.27% |
| Jun 30, 2023 | -13.17% |
| Mar 31, 2023 | 1.71% |
| Dec 31, 2022 | 13.05% |
| Sep 30, 2022 | -7.29% |
| Jun 30, 2022 | -34.19% |
| Mar 31, 2022 | 13.73% |
| Dec 31, 2021 | -15.76% |
| Sep 30, 2021 | -50.95% |
| Jun 30, 2021 | -14.73% |
| Mar 31, 2021 | 24.44% |
| Dec 31, 2020 | -84.40% |
| Sep 30, 2020 | 10.15% |
| Jun 30, 2020 | -107.76% |
| Mar 31, 2020 | 29.75% |
| Dec 31, 2019 | -155.06% |
| Sep 30, 2019 | 27.47% |